Evidence map›Paper›PMID 10234039›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience1999

Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor.

B A Horger, C A Iyasere, M T Berhow, C J Messer, E J Nestler, J R Taylor

Registry-linked trialOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06550167 (Neuroprotective Effect of Omega), which is not on this map. Cited by 147 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
147citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06550167 narecruitingnot on this mapstarted 2024, after this paper: background citation

Neuroprotective Effect of Omega (Nano PSO), Changes in Neurotrophic BDNF and VEGF, and Their Association With Cognitive Status in Patients Who Used to Consume Psychoactive Substances

TypeinterventionalSponsorDistribuidora Biolife SA de CVRan2024 to 2027Enrolled80ConditionsAddiction, Drug(S), LSD, NeuroprotectiveArmsNano-PSO, Pomegranate seed oil (omega-5), PLACEBO
3 · Its place in the literature

Who cites it

147 citing papers in PubMed, 1 synthesis or guideline pooled it, 375 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Voluntary Exercise Boosts Striatal Dopamine Release: Evidence for the Necessary and Sufficient Role of BDNF.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  6. Article
  7. Growth Factors and Alcohol Use Disorder.Cold Spring Harbor perspectives in medicine · 2020
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Reward Circuitry in Addiction.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2017
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

87 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

B A HorgerLaboratory of Molecular Psychiatry, Departments of Psychiatry, Pharmacology, and Neurobiology, Yale University School of Medicine, Connecticut Mental Health Center, New Haven, Connecticut 06520, USA.
C A Iyasere
M T Berhow
C J Messer
E J Nestler
J R Taylor
Connecticut Mental Health Center · USYale University · US

Funding

TRANSGENIC COREP01DA008227 · NIDA · YALE UNIVERSITY · PI NESTLER, ERIC J. · 1993 to 2018
$28.1M
TROPHIC FACTOR/TRANSMITTER INTERACTIONS IN ADDICTIONP01DA010160 · NIDA · YALE UNIVERSITY · PI NESTLER, ERIC J · 1995 to 1999
–
NIDA NIH HHS DA08227NIDA NIH HHS DA10160NIDA NIH HHS P01 DA008227
6 · The paper itself

Abstract

The mesolimbic dopamine (DA) system has been implicated in drug reward, locomotor sensitization, and responding for reward-related stimuli [termed conditioned reinforcers (CR)]. Here, we investigated the effect of brain-derived neurotrophic factor (BDNF), which enhances the survival and function of dopaminergic neurons, on stimulant-induced locomotor sensitization and responding for CR. In experiment 1, BDNF was infused into the nucleus accumbens (NAc) or ventral tegmental area over 2 weeks via chronically implanted minipumps (1-2.5 microgram/d), and the psychomotor stimulant effects of cocaine (5-15 mg/kg, i.p.) were studied. We found that BDNF enhanced the initial stimulant effects of cocaine and seemed to facilitate the development of sensitization to repeated cocaine doses. In experiment 2, we studied the effects of intra-NAc BDNF infusions on responding for CR. BDNF-treated rats showed twice as many CR responses compared with controls when saline was first administered. BDNF enhanced responding on the CR lever more than four times that seen in control animals after a cocaine injection (10 mg/kg, i.p.). The enhanced response to cocaine in BDNF-treated animals persisted for more than a month after the BDNF infusions had stopped, indicating long-lasting changes in the mesolimbic DA system caused by BDNF administration. In experiment 3, we examined locomotor sensitization to cocaine in heterozygous BDNF knock-out mice and found that the development of sensitization was delayed compared with wild-type littermates. These results demonstrate the profound effects of BDNF on the enhancement of both cocaine-induced locomotion and facilitation of CR and suggest a possible role for BDNF in long-term adaptations of the brain to cocaine.

Indexed as

RewardAnimalsBrain-Derived Neurotrophic FactorCocaineConditioning, OperantDopamine Uptake InhibitorsDrug SynergismFemaleInfusion PumpsMaleMiceMice, KnockoutMotor ActivityNerve Growth FactorsRatsRats, Sprague-DawleyBrain-Derived Neurotrophic FactorCocaineDopamine Uptake InhibitorsNerve Growth Factors

Identifiers

PMID10234039
PMCPMC6782687
OpenAlexW1666851979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.